Canadian Institutes of Health Research
570,556 snapshots · latest May 3, 2026
Homepage:https://cihr-irsc.gc.ca/
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
Health Canada
386,223 snapshots · latest Apr 14, 2026
Public Health Agency of Canada
243,880 snapshots · latest Apr 28, 2026
Qualifying notice for Jaypirca (293854) Pharmaceutical Drugs Directorate Holland Cross, Tower "B" 6th Floor, 1600 Scott Street Address Locator #3106B Ottawa ON K1A 0K9 Dossier ID: e286404 Control number: 293854 Eli Lilly Canada Inc. c/o [name of employee removed] Director,…
Qualifying notice for Leqembi (273840) Biologic and Radiopharmaceutical Drugs Directorate 100 Eglantine Driveway LCDC Building Tunney's Pasture, A.L. 0601C Ottawa ON K1A 0K9 Dossier ID: e265497 Control number: 273840 [employee name removed] [employee title removed] Eisai Limited…
Health Canada and the Food and Drug Administration collaborate on generic drug information sharing initiative: Notice December 1, 2025 Our file number: 25-107744 - 234 Health Canada's Pharmaceutical Drugs Directorate (PDD) and the U.S. Food and Drug Administration's (FDA) Office…
Qualifying notice for Eylea (278211) Biologic and Radiopharmaceutical Drugs Directorate 100 Eglantine Driveway LCDC Building Tunney's Pasture, A.L. 0601C Ottawa ON K1A 0K9 Dossier ID: e144515 Control number: 278211 [employee name removed] [employee title removed] Bayer Inc. 2920…
New draft guidance documents on terms and conditions for human and veterinary drugs and drug submissions based on promising evidence of clinical efficacy: Notice December 12, 2025 On this page New agile amendments - terms and conditions Consultation on draft guidance on terms and…
Qualifying notice for Lyvdelzi (294551) Pharmaceutical Drugs Directorate Holland Cross, Tower "B" 6th Floor, 1600 Scott Street Address Locator #3106B Ottawa ON K1A 0K9 Dossier ID: e288949 Control number: 294551 Gilead Sciences Canada Inc. c/o [name of employee removed] [employee…
Notice: Multiple additions to the Prescription Drug List (PDL) [2025-12-18] December 18, 2025 Our file number: 25-108167-776 The purpose of this Notice of Amendment is to announce the addition of bempedoic acid, bexagliflozin, izenivetmab, lecanemab, oritavancin, pirtobrutinib,…
Qualifying notice for Wegovy (296143) Biologic and Radiopharmaceutical Drugs Directorate 100 Eglantine Driveway LCDC Building Tunney's Pasture, A.L. 0601C Ottawa ON K1A 0K9 Dossier ID: e171468 Control number: 296143 [employee name removed] [employee title removed] Novo Nordisk…
Bicillin L‑A (penicillin G benzathine) in short supply: Notice Date published: December 19, 2025 Date updated: March 20, 2026 On this page Background What we're doing What you can do Background Bicillin L-A (penicillin G benzathine) is a prescription drug used to treat certain…
Consultation: Modernizing the framework for clinical trials Current status: Open Opened on December 20, 2025. We have extended the deadline for input to April 19, 2026. Health Canada is seeking feedback on the proposed Clinical Trials Regulations for drugs (pharmaceuticals,…
Early release: coverage and features are still expanding.
